Blood pressure drug urgently recalled over safety concerns
Regulators have issued a recall for more than 3,000 bottles of blood pressure medication after it failed safety tests. The three-in-one pill, which contains olmesartan, amlodipine, and hydrochlorothiazide to relax the blood vessels and eliminate excess water, has failed dissolution tests by regulators.
TL;DR
- Over 3,000 bottles of blood pressure medication recalled by the FDA.
- The medication, containing olmesartan, amlodipine, and hydrochlorothiazide, failed safety dissolution tests.
- The failure suggests the pill may not be absorbed by the body as intended.
- The recall affects approximately 3,744 bottles manufactured by Macleods Pharma USA, Inc.
- This is a Class II recall, indicating potential for temporary or medically reversible adverse health consequences.
- Affected products include 30-count and 90-count bottles with specific NDC, lot numbers, and expiration dates.